The Future of Crohn’s Treatment: 2026 Medical Breakthroughs to Watch

Welcome back to the Healthy Crohn’s blog. Navigating Crohn’s disease often feels like chasing a moving target, but the latest advancements in gastroenterology are giving us entirely new tools to manage it. We’ve compiled the most promising breakthroughs and upcoming therapies from recent clinical research so you can stay informed about what’s on the horizon.
1. TL1A Inhibitors: Fighting Inflammation and Scarring
For years, treatments have focused primarily on stopping inflammation. But a new class of biologic drugs targeting the TL1A protein is being studied because it may also affect scarring, which would be new. Fibrosis (scar tissue) is what causes strictures and often leads to bowel resection surgery. Drugs in this class are still in clinical trials. Researchers do not yet know whether they can reduce scarring in people, so ask your doctor what is known today.
2. Advanced IL-23 Inhibitors: Precision Targeting
While older biologics suppress large portions of the immune system, IL-23 inhibitors act like a sniper, targeting a specific inflammatory protein (interleukin-23). Medications in this category are approved for Crohn’s, have shown remission in trials and can promote endoscopic healing (the actual healing of the bowel lining). They can help some people who have not responded to other biologics. They still carry risks, such as infections, and your doctor will screen you first, for example for tuberculosis and hepatitis B.
3. Next-Generation JAK Inhibitors
JAK inhibitors are small-molecule medications taken as a pill that block the Janus kinase pathways involved in immune signaling. Upadacitinib (Rinvoq) is approved for adults with moderate-to-severe Crohn’s who have not done well on at least one TNF blocker. Its label carries a boxed warning for serious infections, death, cancer, heart events and blood clots, so your doctor will weigh the risks with you. A pill is convenient, but it is not right for everyone.
4. Stem Cell Therapy for Tissue Repair
Mesenchymal stem cell (MSC) therapy has been tested as a way to repair damaged tissue, especially for perianal fistulas, a hard-to-treat complication that affects many people with Crohn’s. Results have been mixed. A large trial of one stem cell product, Alofisel, did not show a benefit over placebo, and it was withdrawn from the EU market in December 2024. This field is still research, not a standard treatment.
5. Genetic Discovery: The CARD9 Variant
In a fascinating pipeline development, researchers have designed small molecules that actually mimic a rare gene variant known to protect against inflammatory bowel disease. These molecules target the CARD9 protein, selectively blocking chronic inflammatory signaling without shutting down the immune system’s overall ability to fight off regular gut infections. While still in the early development phase, it shows one way that gene discoveries could lead to new treatments someday.
This post is general information, not medical advice. Ask your gastroenterologist which treatments fit you.
Get Healthy Crohns on Google Play
Track food, sleep, meds and symptoms privately on your phone.
An iPhone version is currently in production.
Or get new articles and app updates by email:
I am not a doctor. This is not medical advice. Check with your care team before changing treatment, diet or supplements.


